. . . . . . . "[TXNIP mediates hepatic lipogenesis via PRMT1 and PGC-1? regulation and inflammation in vitro and in vivo, implying that targeting TXNIP and PRMT1 is a potential therapeutic approach for treatment of NAFLD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:29+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .